Alcide Barberis - 29 Oct 2026 Form 4 Insider Report for OSR Health, Inc. (OSRH)

SEC form
4
Accepted by SEC
19 Nov 2026, 08:12:05 UTC
Prior SEC filing
21 Feb 2025
Source filing
View source filing
Filing notes and source

Key filing fact

Alcide Barberis filed Form 4 for OSR Health, Inc. (OSRH) on 19 Nov 2026.

Key facts

  • This page summarizes Alcide Barberis's Form 4 filing for OSR Health, Inc. (OSRH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Nov 2026, 08:12.

Change

  • Previous filing in this sequence was filed on 21 Feb 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002057466 Primary reporting owner

Barberis Alcide

Relationship
Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OSRH transaction

OSRH

Award

Transaction value
Shares
+120,000
Change %
Price
$0.000000*
Shares after
120,000
Date
29 Oct 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan. The shares are subject to a six-month contractual lock-up from the grant date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .